4.7 Article

Pain scoring in endometriosis: entry criteria and outcome measures for clinical trials. Report from the Art and Science of Endometriosis meeting

期刊

FERTILITY AND STERILITY
卷 93, 期 1, 页码 62-67

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2008.09.056

关键词

Endometriosis; pain; quality of life; dysmenorrhea

资金

  1. National Institute of Child Health and Human Development
  2. Ferring
  3. Neurocrine
  4. Pfizer
  5. Schering
  6. Takeda
  7. TAP Pharmaceuticals
  8. EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008769, ZIEHD008737] Funding Source: NIH RePORTER
  9. EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008769] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Standardized entry criteria and outcome measures for clinical trials in endometriosis-related pain would facilitate the comparison of trial results and the production of systematic reviews, improving evidence-based practice in this area. This report summarizes the recommendations from an international meeting for these criteria. (Fertil Steril(R) 2010;93:62-7. (C)2010 by American Society for Reproductive Medicine.)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据